Loading clinical trials...
Loading clinical trials...
The Hemolytic Uremic Syndrome (HUS) in its typical form occurs after a food born infection with a shiga-toxin secreting bacteria, usually Escherichia coli of the O157H7 serotype. An outbreak of bloody...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Bordeaux
NCT06389474 · Hemolytic-Uremic Syndrome
NCT05219110 · Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome
NCT03869593 · Escherichia Coli Infections, Staphylococcus Aureus
NCT04132375 · Bloody Diarrhea, STEC, Unspecified, and more
NCT02729116 · Anti-Infective Agents, Urinary, Escherichia Coli Infections, and more
Service de Néphrologie, transplantation dialyse - Hôpital Pellegrin
Bordeaux
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions